{"id":"https://openalex.org/W4361888930","doi":"https://doi.org/10.1158/1078-0432.22477730","title":"Supplementary Table 3 from A Phase I/II Study of Veliparib (ABT-888) in Combination with 5-Fluorouracil and Oxaliplatin in Patients with Metastatic Pancreatic Cancer","display_name":"Supplementary Table 3 from A Phase I/II Study of Veliparib (ABT-888) in Combination with 5-Fluorouracil and Oxaliplatin in Patients with Metastatic Pancreatic Cancer","publication_year":2023,"publication_date":"2023-03-31","ids":{"openalex":"https://openalex.org/W4361888930","doi":"https://doi.org/10.1158/1078-0432.22477730"},"language":"en","primary_location":{"id":"doi:10.1158/1078-0432.22477730","doi":"https://doi.org/10.1158/1078-0432.22477730","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1078-0432.22477730","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"volume":null,"type":"supplementary-materials","indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://doi.org/10.1158/1078-0432.22477730","any_repository_has_fulltext":null},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5021453899","display_name":"Michael Jon Pishvaian","orcid":"https://orcid.org/0000-0002-1165-9041","observed_orcids":["https://orcid.org/0000-0002-1165-9041"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Michael J. Pishvaian","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-1165-9041","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101805458","display_name":"Hongkun Wang","orcid":"https://orcid.org/0000-0002-7150-6477","observed_orcids":["https://orcid.org/0000-0002-7150-6477"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Hongkun Wang","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5045096676","display_name":"Aiwu Ruth He","orcid":"https://orcid.org/0000-0002-2104-0816","observed_orcids":["https://orcid.org/0000-0002-2104-0816"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Aiwu Ruth He","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5104103465","display_name":"Jimmy J. Hwang","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jimmy J. Hwang","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5024146796","display_name":"Brandon George Smaglo","orcid":"https://orcid.org/0000-0002-8814-8004","observed_orcids":["https://orcid.org/0000-0002-8814-8004"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Brandon G. Smaglo","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-8814-8004","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5070721086","display_name":"Sunnie S. Kim","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Sunnie S. Kim","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5055915497","display_name":"Benjamin Adam Weinberg","orcid":"https://orcid.org/0000-0002-0408-4817","observed_orcids":["https://orcid.org/0000-0002-0408-4817"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Benjamin A. Weinberg","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-0408-4817","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5045107557","display_name":"Louis M. Weiner","orcid":"https://orcid.org/0000-0001-5192-0710","observed_orcids":["https://orcid.org/0000-0001-5192-0710"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Louis M. Weiner","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-5192-0710","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5061373605","display_name":"John Lindsay Marshall","orcid":"https://orcid.org/0000-0002-3449-2344","observed_orcids":["https://orcid.org/0000-0002-3449-2344"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"John L. Marshall","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-3449-2344","affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5079398934","display_name":"Jonathan Robert Brody","orcid":"https://orcid.org/0000-0003-3680-3270","observed_orcids":["https://orcid.org/0000-0003-3680-3270"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jonathan R. Brody","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11914","display_name":"PARP inhibition in cancer therapy","score":0.5946999788284302,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11914","display_name":"PARP inhibition in cancer therapy","score":0.5946999788284302,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10231","display_name":"Pancreatic and Hepatic Oncology Research","score":0.4025999903678894,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10760","display_name":"Pancreatitis Pathology and Treatment","score":0.0006000000284984708,"subfield":{"id":"https://openalex.org/subfields/2746","display_name":"Surgery"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/veliparib","display_name":"veliparib","score":0.9959999918937683},{"id":"https://openalex.org/keywords/5-fluorouracil","display_name":"5-fluorouracil","score":0.9390000104904175},{"id":"https://openalex.org/keywords/oxaliplatin","display_name":"oxaliplatin","score":1.0},{"id":"https://openalex.org/keywords/metastatic-pancreatic-cancer","display_name":"metastatic pancreatic cancer","score":0.9929999709129333},{"id":"https://openalex.org/keywords/parp-inhibitors","display_name":"PARP inhibitors","score":0.8019999861717224},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.9079999923706055},{"id":"https://openalex.org/keywords/combination-chemotherapy","display_name":"combination chemotherapy","score":0.7559999823570251}],"concepts":[{"id":"https://openalex.org/C2781312401","wikidata":"https://www.wikidata.org/wiki/Q7919041","display_name":"Veliparib","level":5,"score":0.9816266298294067},{"id":"https://openalex.org/C2780962732","wikidata":"https://www.wikidata.org/wiki/Q422327","display_name":"Oxaliplatin","level":4,"score":0.7488311529159546},{"id":"https://openalex.org/C2780456651","wikidata":"https://www.wikidata.org/wiki/Q238512","display_name":"Fluorouracil","level":3,"score":0.6729251742362976},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.5941523313522339},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5543547868728638},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.5486987829208374},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5395352840423584},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.33497875928878784},{"id":"https://openalex.org/C526805850","wikidata":"https://www.wikidata.org/wiki/Q188874","display_name":"Colorectal cancer","level":3,"score":0.24633944034576416},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.16966098546981812},{"id":"https://openalex.org/C182979987","wikidata":"https://www.wikidata.org/wiki/Q3907241","display_name":"Poly ADP ribose polymerase","level":4,"score":0.1289139986038208},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.0},{"id":"https://openalex.org/C82381507","wikidata":"https://www.wikidata.org/wiki/Q416878","display_name":"Polymerase","level":3,"score":0.0},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1078-0432.22477730","doi":"https://doi.org/10.1158/1078-0432.22477730","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1078-0432.22477730","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"}],"best_oa_location":{"id":"doi:10.1158/1078-0432.22477730","doi":"https://doi.org/10.1158/1078-0432.22477730","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1078-0432.22477730","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9763000011444092,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4361961618","https://openalex.org/W3042953038","https://openalex.org/W3204487449","https://openalex.org/W4361958012","https://openalex.org/W2657871503","https://openalex.org/W2946919317","https://openalex.org/W1985146915","https://openalex.org/W4361946748","https://openalex.org/W3153250761","https://openalex.org/W2521377778"],"abstract_inverted_index":{"Veliparib":[0],"pharmacokinetics":[1],"compared":[2],"to":[3],"historical":[4],"control.":[5]},"counts_by_year":[],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2023-04-05T00:00:00"}